Financials

  • Market Capitalization 7.59 M
  • Employee 8
  • Founded 2011
  • CEO Paul Kang
  • Website www.exicuretx.com
  • Headquarter Delaware, United States
  • FIGI BBG00GTJCSB4
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-6.86
ratio cours/chiffre d'affaires
—

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
4734
TCRT
Alaunos Therapeutics, Inc. - Common Stock
3.03 USD+188.57%+309.46%+103.36%+13.52%7.70 M USD
4735
CURX
Curanex Pharmaceuticals Inc - Common Stock
4.88 USD-8.10%+1.88%+10.66%+674.60%7.65 M USD
4740
APRE
Aprea Therapeutics, Inc. - Common Stock
0.60 USD+1.69%-4.76%-22.08%-60.26%7.55 M USD
4742
SNGX
Soligenix, Inc. - Common Stock
0.33 USD-5.71%-8.33%-10.81%-70.80%7.18 M USD

Nouvelles